Excedr

Bexorg transforms CNS drug discovery with AI-powered whole-human brain platform—Excedr covers this major biotech funding round.

Lila Sciences pioneers autonomous AI labs, raising $550M to build scientific superintelligence—Excedr covers this major biotech funding round.

Kailera Therapeutics raises $1B to advance KAI-9531 obesity drug—Excedr covers this major biotech funding round.

Salt AI secures $10M funding to advance AI-powered drug discovery—Excedr covers this major biotech funding round.

Expedition Therapeutics secures $165M Series A to advance EXPD-101, a first-in-class oral DPP-1 inhibitor for COPD—Excedr covers this major biotech funding round.

Lumen Bioscience pioneers affordable oral biologic drugs using engineered spirulina—Excedr covers this major biotech funding round.

Multiphoton microscopes unlock deep-tissue fluorescence imaging and advanced techniques but carry steep costs. This guide breaks down price ranges, hidden expenses, and access models—helping biotech startups decide when to buy, lease, or outsour

MALDI-TOF MS is a powerful tool in proteomics and diagnostics, but the price tag isn’t straightforward. From $150K instruments to million-dollar builds, plus service, reagents, and workflow costs, here’s how to decide whether buying, leasing, or

Lyophilizers are essential for stability studies and biotech workflows, but costs vary widely. This guide breaks down price ranges, hidden expenses, and whether buying, leasing, or outsourcing makes sense for your stage and budget.

An ICP-MS can transform a biotech lab, but costs run far beyond the sticker price. This guide breaks down price ranges, hidden expenses, and practical options for startups deciding whether to buy, lease, or outsource.